Tag: teligent

April 4, 2019

Teligent Receives FDA Approval of Fluocinonide Cream USP, 0.1 Percent

Teligent (NASDAQ:TLGT) has announced it has received approval for its abbreviated new drug application from the US Food and Drug...
March 14, 2019

Teligent Announces FDA Approval of Desonide Ointment

Teligent (NASDAQ:TLGT) has announced it has received approval from the FDA for its abbreviated new drug application (ANDA) of desonide...
December 14, 2018

Teligent Executes $120 Million Financing Agreement

Teligent (NASDAQ:TLGT) announced today that on December 13, 2018 the Company entered into a definitive first lien revolving credit agreement with...
October 24, 2018

Teligent Announces FDA Approval of Desoximetasone Ointment USP 0.05%

Teligent (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company’s abbreviated new...
October 17, 2018

Teligent Announces FDA Approval of Fluocinonide Cream USP, 0.05%

Teligent (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company’s abbreviated new...
October 2, 2018

Teligent Announces FDA Approval of Fluocinonide Ointment USP, 0.05%

Teligent (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company’s abbreviated new...
July 10, 2018

Pharmaceutical Update: Q2 2018 in Review

With Q2 officially behind us and Q3 already in full swing, here the Investing News Network is providing a look...